Risk Factors Associated with Premalignant and Malignant Endometrial Polyps
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objectives: The objective of this study is to evaluate the prevalence of endometrial premalignant and malignant polyps in women who underwent hysteroscopic polypectomies, and to investigate whether clinical parameters predict histopathologic outcomes. Methods: A review was carried out on the medical records of patients who had undergone hysteroscopic endometrial polypectomy from January 2010 to December 2011. One thousand one hundred ninety-six women who ranged in age from 16 to 81 years were included in the study. Polyps were classified as benign (endometrial polyps and polyps with non-atypical simple hyperplasia and non-atypical complex hyperplasia), premalignant (polyps with atypical simple hyperplasia or atypical complex hyperplasia), or malignant. A statistical analysis was then performed. Results: Histopathologically, 96.7% benign, 1.1% premalignant, and 2.2% malignant lesions were detected. Abnormal uterine bleeding and postmenopause were the only factors which were determined to be associated with a higher risk of malignancy, with an odds ratios of 5.07 (95% CI, 2.25-11.41) and 3.41 (95% CI, 1.14-10.24), respectively. Conclusion: The risk factors associated with premalignant and malignant endometrial polyps include abnormal uterine bleeding and menopause.
Abstract
Objectives: The objective of this study is to evaluate the prevalence of endometrial premalignant and malignant polyps in women who underwent hysteroscopic polypectomies, and to investigate whether clinical parameters predict histopathologic outcomes. Methods: A review was carried out on the medical records of patients who had undergone hysteroscopic endometrial polypectomy from January 2010 to December 2011. One thousand one hundred ninety-six women who ranged in age from 16 to 81 years were included in the study. Polyps were classified as benign (endometrial polyps and polyps with non-atypical simple hyperplasia and non-atypical complex hyperplasia), premalignant (polyps with atypical simple hyperplasia or atypical complex hyperplasia), or malignant. A statistical analysis was then performed. Results: Histopathologically, 96.7% benign, 1.1% premalignant, and 2.2% malignant lesions were detected. Abnormal uterine bleeding and postmenopause were the only factors which were determined to be associated with a higher risk of malignancy, with an odds ratios of 5.07 (95% CI, 2.25-11.41) and 3.41 (95% CI, 1.14-10.24), respectively. Conclusion: The risk factors associated with premalignant and malignant endometrial polyps include abnormal uterine bleeding and menopause.
참고문헌 (32)
- Antunes A Jr, "Endometrial polyps in pre- and postmenopausal women: factors associated with malignancy", Maturitas, 57, pp.415~421 (2007)
- Peterson WF, "Endometrial polyps", Obstet Gynecol, 8, pp.40~49 (1956)
- Savelli L, "Histopathologic features and risk factors for benignity, hyperplasia, and cancer in endometrial polyps", Am J Obstet Gynecol, 188, pp.927~931 (2003)
- Ben-Arie A, "The malignant potential of endometrial polyps", Eur J Obstet Gynecol Reprod Biol, 115, pp.206~210 (2004)
- Shushan A, "How often are endometrial polyps malignant", Gynecol Obstet Invest, 58, pp.212~215 (2004)
- Ferrazzi E, "How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study", Am J Obstet Gynecol, 200, pp.235.e1~235.e6 (2009)
- Machtinger R, "Transvaginal ultrasound and diagnostic hysteroscopy as a predictor of endometrial polyps: risk factors for premalignancy and malignancy", Int J Gynecol Cancer, 15, pp.325~328 (2005)
- Goldstein SR, "Ultrasonography-based triage for perimenopausal patients with abnormal uterine bleeding", Am J Obstet Gynecol, 177, pp.102~108 (1997)
- Baiocchi G, "Malignancy in endometrial polyps: a 12- year experience", Am J Obstet Gynecol, 201, pp.462.e1~462.e4 (2009)
- Lee SC, "The oncogenic potential of endometrial polyps: a systematic review and meta-analysis", Obstet Gynecol, 116, pp.1197~1205 (2010)
- Wang JH, "Opportunities and risk factors for premalignant and malignant transformation of endometrial polyps: management strategies", J Minim Invasive Gynecol, 17, pp.53~58 (2010)
- Gregoriou O, "Clinical parameters linked with malignancy in endometrial polyps", Climacteric, 12, pp.454~458 (2009)
- Rahimi S, "Endometrial polyps and the risk of atypical hyperplasia on biopsies of unremarkable endometrium: a study on 694 patients with benign endometrial polyps", Int J Gynecol Pathol, 28, pp.522~528 (2009)
- Domingues AP, "Endometrial polyps in postmenopausal women", Acta Obstet Gynecol Scand, 88, pp.618~620 (2009)
- Ferenczy A, "The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia", Am J Obstet Gynecol, 160, pp.126~131 (1989)
- Kurman RJ, "The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients", Cancer, 56, pp.403~412 (1985)
- Sivridis E, "Prognostic aspects on endometrial hyperplasia and neoplasia", Virchows Arch, 439, pp.118~126 (2001)
- The Rotterdam ESHRE, "ASRM-sponsored PCOS consensus workshop group.", Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS), 2004, pp.19, 41~47
- Lee SH, "폐경 여성의 부인과 응급 환자에 대한 임상적 고찰", 대한폐경학회지, 18(2), pp.119~123 (2012), 대한폐경학회[DOI]
- Lacey JV Jr, "Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia", J Clin Oncol, 28, pp.788~792 (2010)
- Trimble CL, "Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study", Cancer, 106, pp.812~819 (2006)
- 조연진, "자궁내막폴립의 악성화 빈도와 관련 인자", Obstetrics & Gynecology Science, 50(1), pp.180~186 (2007), 대한산부인과학회
- Cravello L, "Hysteroscopic surgery in postmenopausal women", Acta Obstet Gynecol Scand, 75, pp.563~566 (1996)
- Tjarks M, "Treatment of endometrial polyps", Obstet Gynecol, 96, pp.886~889 (2000)
- American Association of Gynecologic Laparoscopists, "AAGL practice report: practice guidelines for the diagnosis and management of endometrial polyps", J Minim Invasive Gynecol, 19, pp.3~10 (2012)
- Wethington SL, "Risk and predictors of malignancy in women with endometrial polyps", Ann Surg Oncol, 18, pp.3819~3823 (2011)
- Costa-Paiva L, "Risk of malignancy in endometrial polyps in premenopausal and postmenopausal women according to clinicopathologic characteristics", Menopause, 18, pp.1278~1282 (2011)
- Fernández-Parra J, "Hysteroscopic evaluation of endometrial polyps", Int J Gynaecol Obstet, 95, pp.144~148 (2006)
- Speleman F, "Is t(6;20)(p21;q13) a characteristic chromosome change in endometrial polyps", Genes Chromosomes Cancer, 3, pp.318~319 (1991)
- Dal Cin P, "The 6p21 chromosome region is nonrandomly involved in endometrial polyps", Gynecol Oncol, 46, pp.393~396 (1992)
- Oguz S, "The role of hormone replacement therapy in endometrial polyp formation", Maturitas, 50, pp.231~236 (2005)
- Bergman L, "Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres’ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen", Lancet, 356, pp.881~887 (2000)